Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Similac Toxic Infant Formula Lawsuit
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
See all news
7.26.2012

Bard, Doctor Ordered to Pay $5.5 Million Over Implant

Bloomberg News, by Jef Feeley (July 25, 2012) — C.R. Bard Inc. and a doctor must pay a total of $5.5 million in damages over a vaginal-mesh implant that left a woman incontinent and in chronic pain, a jury ruled in the first case over the devices to go to trial.

Jurors in state court in Bakersfield, California, concluded July 20 that Christine Scott and her husband deserved the damage award because of injuries caused by Bard’s Avaulta Plus vaginal implant, Elaine Houghton, one of the couple’s lawyers, said in a phone interview yesterday.

The panel found Bard officials were negligent in their handling of the devices, used to treat pelvic organs that bulge, or prolapse, or to deal with incontinence, she said.

“They seemed to focus on evidence we produced showing that Bard didn’t properly test the product before putting it on the market,” Houghton said. The lawyer said she asked jurors to consider awarding as much as $11 million in damages to the couple over the implant.

The case is the first to go to trial among hundreds of lawsuits alleging that implants made by Murray Hill, New Jersey- based Bard, Boston Scientific Corp. (BSX) (BSX) and other companies caused organ damage. The decision comes more than a month after Johnson & Johnson (JNJ) (JNJ)’s Ethicon unit announced it would stop selling four lines of vaginal mesh devices.

In its verdict, the California jury found Bard was 60 percent at fault for Scott’s injuries while Dr. Tillakarasi Kannappan, who surgically implanted the device in 2008, was responsible for the other 40 percent of the liability, according a copy of the verdict sheet filed with the court.

For the remainder of this article, please visit Bloomberg News.

Wexler Wallace represents a number of women who have suffered complications from implanted surgical mesh. If you or a loved one suffered complications after use of Transvaginal Surgical Mesh to treat Pelvic Organ Prolapse or Stress Urinary Incontinence, please contact us or fill out our online form.

Share

  • Facebook
  • Twitter
  • LinkedIn
Image

311 S. Wacker Drive,
Suite 5450
Chicago, IL 60606
P_312.346.2222
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2022 © Wexler Boley & Elgersma LLP